1. Home
  2. ET vs BDX Comparison

ET vs BDX Comparison

Compare ET & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ET
  • BDX
  • Stock Information
  • Founded
  • ET 2002
  • BDX 1897
  • Country
  • ET United States
  • BDX United States
  • Employees
  • ET N/A
  • BDX N/A
  • Industry
  • ET Natural Gas Distribution
  • BDX Medical/Dental Instruments
  • Sector
  • ET Utilities
  • BDX Health Care
  • Exchange
  • ET Nasdaq
  • BDX Nasdaq
  • Market Cap
  • ET N/A
  • BDX 64.9B
  • IPO Year
  • ET 2006
  • BDX 1962
  • Fundamental
  • Price
  • ET $18.95
  • BDX $227.51
  • Analyst Decision
  • ET Strong Buy
  • BDX Strong Buy
  • Analyst Count
  • ET 12
  • BDX 7
  • Target Price
  • ET $22.08
  • BDX $278.29
  • AVG Volume (30 Days)
  • ET 15.5M
  • BDX 2.0M
  • Earning Date
  • ET 05-07-2025
  • BDX 05-01-2025
  • Dividend Yield
  • ET 6.87%
  • BDX 1.83%
  • EPS Growth
  • ET 17.66
  • BDX 41.25
  • EPS
  • ET 1.28
  • BDX 5.94
  • Revenue
  • ET $82,671,000,000.00
  • BDX $20,640,000,000.00
  • Revenue This Year
  • ET $12.03
  • BDX $9.21
  • Revenue Next Year
  • ET $3.13
  • BDX $4.97
  • P/E Ratio
  • ET $14.56
  • BDX $38.29
  • Revenue Growth
  • ET 5.20
  • BDX 5.89
  • 52 Week Low
  • ET $14.90
  • BDX $218.75
  • 52 Week High
  • ET $21.45
  • BDX $251.99
  • Technical
  • Relative Strength Index (RSI)
  • ET 52.03
  • BDX 47.13
  • Support Level
  • ET $18.45
  • BDX $226.48
  • Resistance Level
  • ET $19.13
  • BDX $230.95
  • Average True Range (ATR)
  • ET 0.42
  • BDX 3.71
  • MACD
  • ET 0.13
  • BDX 0.25
  • Stochastic Oscillator
  • ET 94.78
  • BDX 47.96

About BDX Becton Dickinson and Company

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.

Share on Social Networks: